Format

Send to

Choose Destination
See comment in PubMed Commons below
Hum Reprod. 2005 Dec;20(12):3284-92. Epub 2005 Aug 11.

Cost--effectiveness analysis of salpingectomy prior to IVF, based on a randomized controlled trial.

Author information

1
Reproductive Medicine, Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Göteborg, Sweden. annika.strandell@medfak.gu.e

Abstract

BACKGROUND:

In patients with ultrasound-visible hydrosalpinges, salpingectomy prior to IVF increases the chance of a live birth. This study compared the cost-effectiveness of this strategy (intervention) with that of optional salpingectomy after a failed cycle (control).

METHODS:

Data from a Scandinavian randomized controlled trial were used to calculate the individual number of treatments and their outcomes. Only patients with ultrasound-visible hydrosalpinges were considered in the main analysis, and a maximum of three fresh cycles were included. The costs for surgical procedures, IVF treatment, medication, complications, management of pregnancy and delivery as well as of early pregnancy losses were calculated from standardized hospital charges.

RESULTS:

Among the 51 patients in the intervention group, the live birth rate was 60.8% compared with 40.9% in 44 controls. The average cost per patient was 13,943 euro and 12,091 euro, respectively. Thus, the average cost per live birth was 22,823 euro in the intervention group and 29,517 euro in the control group. The incremental cost-effectiveness ratio for adopting the intervention strategy was estimated at 9306 euro.

CONCLUSIONS:

The incremental cost to achieve the higher birth rate of the intervention strategy seems reasonable.

PMID:
16096324
DOI:
10.1093/humrep/dei244
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center